Edition:
United Kingdom

Innovate Biopharmaceuticals Inc (INNT.OQ)

INNT.OQ on NASDAQ Stock Exchange Capital Market

5.40USD
4:02pm GMT
Change (% chg)

$0.40 (+8.00%)
Prev Close
$5.00
Open
$5.20
Day's High
$5.40
Day's Low
$5.20
Volume
7,923
Avg. Vol
4,795
52-wk High
$23.50
52-wk Low
$3.43

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.14 -0.161
Jun '17 0.19 -0.194
Mar '17 0.95 -0.280
FY 2016 Dec '16 1.07 -0.159
Sep '16 0.78 -0.265
Jun '16 1.68 -0.154
Mar '16 0.54 -0.233
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. -- 292.71 45.97
P/E Low - Last 5 Yrs. -- 91.44 24.37
Beta -- 0.90 0.89
Price to Sales (TTM) 1.94 110.72 5.77
Price to Book (MRQ) -- 13.56 5.41
Price to Tangible Book (MRQ) -- 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions 1.38 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -88.89 398.33 9.24
Sales (TTM) vs TTM 1 Yr. Ago -61.60 78.63 5.59
Sales - 5 Yr. Growth Rate -- 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -26.12 25.10 19.65
EPS (TTM) vs TTM 1 Yr. Ago 4.49 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate -- 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.15 1.80 2.18
Current Ratio (MRQ) 0.31 5.30 2.97
LT Debt to Equity (MRQ) -- 22.82 12.22
Total Debt to Equity (MRQ) -- 24.47 16.52
Interest Coverage (TTM) -3.93 -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 5.80 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -248.84 -- --
EBITD - 5 Yr. Avg -- -572.68 10.86
Operating Margin (TTM) -232.32 -717.10 4.64
Operating Margin - 5 Yr. Avg. -- -594.00 6.26
Pre-Tax Margin (TTM) -233.62 -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -- -597.35 6.60
Net Profit Margin (TTM) -233.69 -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -- -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,602,121 855,667,832
Net Income/Employee (TTM) -- 2,968,747 100,655,557
Receivable Turnover (TTM) 4.77 20.14 5.78
Inventory Turnover (TTM) 3.44 2.36 3.35
Asset Turnover (TTM) 0.63 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -147.16 -1.05 10.98
Return on Assets - 5 Yr. Avg. -- -0.57 12.37
Return on Investment (TTM) -- 1.66 14.43
Return on Investment - 5 Yr. Avg. -- 2.23 16.18
Return on Equity (TTM) -- 2.58 16.13
Return on Equity - 5 Yr. Avg. -- 3.13 17.47
  1 Year 3 Year 5 Year
Sales % -50.82 5.68 --
EPS (TTM) % -3.76 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Innovate Biopharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 1.94%
# of Holders: 8
Total Shares Held: 27,870
3 Mo. Net Change: 2,497
# New Positions: 3
# Closed Positions: 2
# Increased Positions: 4
# Reduced Positions: 4
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.